SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001341004-17-000538
Filing Date
2017-08-29
Accepted
2017-08-29 16:55:38
Documents
1
Group Members
JLL ASSOCIATES V (PATHEON), L.P.JLL PARTNERS FUND V (NEW PATHEON), L.P.JLL PARTNERS FUND VI (PATHEON), L.P.JLL PATHEON CO-INVESTMENT FUND, L.P.JLL PATHEON FF II, LLCJLL/DELTA PATHEON GP, LTD.JLL/DELTA PATHEON HOLDINGS, L.P.PATHEON HOLDCO COOPERATIEF U.A.

Document Format Files

Seq Description Document Type Size
1 FORM SC 13D/A FOR JLL ASSOCIATES G.P. V (PATHEON), LTD. sc13da.htm SC 13D/A 267348
  Complete submission text file 0001341004-17-000538.txt   269406
Mailing Address EVERT VAN DE BEEKSTRAAT 104 AMSTERDAM SCHIPHOL P7 1118 CN
Business Address EVERT VAN DE BEEKSTRAAT 104 AMSTERDAM SCHIPHOL P7 1118 CN 31 (20) 622-3243
Patheon N.V. (Subject) CIK: 0001643848 (see all company filings)

IRS No.: 981153534 | State of Incorp.: P7 | Fiscal Year End: 1031
Type: SC 13D/A | Act: 34 | File No.: 005-89586 | Film No.: 171058537
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O JLL PARTNERS 450 LEXINGTON AVE., 31ST FLOOR NEW YORK NY 10017
Business Address C/O JLL PARTNERS 450 LEXINGTON AVE., 31ST FLOOR NEW YORK NY 10017 (212) 286-8600
JLL Associates G.P. V (Patheon), Ltd. (Filed by) CIK: 0001679434 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A